FDA_form_3398_-_Commitment_to_Protect_NPI_Agreement.pdf

FDA Form PDF 5 KB Posted

Attached to
FDA Nonclinical Information Management System (NIMS)
Solicitation number
FDA-SOL-13-1116203
Issued by

About this file

Attachment 8 - Contractors NDA

View the file

Other versions and copies of FDA Form 3398

File Revision Posted Attached to
Attachment 1 FDA FORM 3398.docx Revision not stated CNS Organoid Neuropharmacological Analysis
Attachment J-7 - Commitment to Protect Non-Public Information Employee Agreement FDA Form 3398.pdf Revision not stated National Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support services
C4_FDA_Form 3398_ Non Public Agreement.pdf Revision not stated FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
C4_FDA_Form 3398_ Non Public Agreement.pdf Revision not stated FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
Att D - FDA Form 3398.pdf Revision not stated Safe Medication Use
Attachment 4 FDA Form 3398.pdf Revision not stated FDA NCTR On-Site Pathology Services
Attachment 4 - FDA Form 3398.pdf Revision not stated Jefferson Laboratories On-Site Laboratory Equipment Maintenance, Repair, and Fabrication Services
Attachment 4 FDA Form 3398.pdf Revision not stated Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
FDA FORM 3398.pdf Revision not stated Mass Spectrometry Analysis of Human Plasma Samples
FDA FORM 3398.pdf Revision not stated Whole Exome Sequencing
Attachment 1 FDA FORM 3398.pdf Revision not stated Quantitative proteomics measurement for human COVID-19 plasma samples
Attachment 1 FDA FORM 3398.pdf Revision not stated Quantitative proteomics measurement for human COVID-19 plasma samples
FDA FORM 3398.pdf Revision not stated miRNA Whole Transcriptome Assay (WTA) Service in Human Plasma Samples
Attachment 1 FDA FORM 3398.pdf Revision not stated Whole Exome Sequencing (WES)
Attachment J-12 FDA Form 3398.pdf Revision not stated Bldg. 2 - Chiller Plant Construction and Associated Projects
FDA Form 3398 - Confidenciality Agreement _ ucm013733.pdf Revision not stated discrimination studies in adult rodents to evaluate whether drugs with different mechanism of actions, but similar behavioral effects produce full, partial, or no generalization to each other.
Attachment J8 - FDA Form 3398.pdf Revision not stated Amendment 1 -Construction of Production Water Well at NCTR
Attachment J7 - FDA Form 3398 Commitment to Protect Non-Public Information .pdf Revision not stated NCTR Road & Drainage Improvements
Attachment J-6 FDA Form 3398.pdf Revision not stated FDA Jefferson Labs, Bldg. 5(D) roof replacement to include demolition and renovation of interior space
Atch_7_FDA_Form_3398.pdf Revision not stated SIRCE
Show all 20

Who attaches FDA Form 3398

Other files

Show all 21

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Public Health Service

FOOD AND DRUG ADMINISTRATION

CONTRACTOR’S COMMITMENT TO PROTECT

NON-PUBLIC INFORMATION (NPI) AGREEMENT

Whereas access to non-public information (NPI) from the files of the Food and Drug Administration

(FDA) is required in the performance of my official duties, under Contract Number , and between FDA and my employer, I, , hereby agree that I shall not further release, publish or disclose such information and I shall protect such information entrusted to me in accordance with the provisions of 21 U.S.C. § 331(j), 21 U.S.C. § 360(j), 18 U.S.C. § 1905, as well as other applicable statutory and regulatory provisions.

FORM FDA 3398 (9/99) Created by: PSC Media Arts Branch (301) 443-2454

Further, I agree to:

1. Store NPI in the secured offices of the FDA or in FDA approved contractor facility containers if work is performed off an FDA site.

2. Grant access to NPI only to known employees of the FDA or to other persons designated in writing by the FDA.

3. Return all NPI and any pertinent notes to the FDA Project Officer I am assigned to upon completion of the contract, or at any time upon the FDA’s request.

4. Report in writing to the FDA Project Officer I am assigned to, all incidents in which unauthorized persons may have gained access to any NPI entrusted to me.

I understand the provisions of 21 U.S.C. § 331(j), 21 U.S.C. § 360(j), 18 U.S.C. § 1905 and that I am subject to criminal penalties prescribed by law for any violation thereof.

Signature: Date:

Type or Print Name:

Witnessed by: Date:

Type or Print Name:

EF

File details come from the government source that posted it. Updated .